| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 0 | 0 | 2001 | 2019 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.430 | None | 0.667 | 1 | 1 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 7 | 1996 | 2017 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 0 | 0 | 1984 | 2020 | ||||||||
|
arylsulfatase A | 0.448 | 0.923 | 1.1E-11 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 1990 | 1990 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.430 | None | 1.000 | 3 | 9 | 2006 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 3 | 5 | 1993 | 2019 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 3 | 2 | 1995 | 2019 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.180 | None | 1.000 | 2 | 1 | 2009 | 2018 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 2 | 2 | 2002 | 2020 | ||||||||
|
ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 0.551 | 0.885 | 2.8E-15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2010 | 2011 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2015 | 2017 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2006 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.100 | None | 1.000 | 1 | 17 | 2017 | 2017 | |||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.859 | 1 | 1 | 1997 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1997 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1995 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.500 | None | 0.750 | 1 | 1 | 2006 | 2019 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.500 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 16 | 10 | 2009 | 2019 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 13 | 9 | 1999 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
disease | 0.140 | None | 1.000 | 8 | 5 | 2011 | 2019 |